Catalent Pharma Solutions

Latest Headlines

Latest Headlines

Catalent inks a biosimilar alliance with a Chinese drugmaker

Catalent has signed a deal to lend its biologics development technology to China's Zhejiang Hisun Pharmaceuticals and help the drugmaker get working on copies of some top-selling drugs.

Catalent to expand in U.S. and add 230 jobs to its Kansas City operation

Catalent Pharma Solutions has been steadily expanding its manufacturing capabilities around the world and is now set to beef up in the center of the U.S. The move will add more than 230 jobs to its operation in Kansas City, MO.

Catalent kicks off $35M expansion in U.S.

Contract manufacturer Catalent Pharma Solutions is expanding again, this time at a controlled release drug manufacturing facility in Winchester, KY, with a little help from that state.

Catalent deals target China from 2 directions

More and more companies are looking for the best way to capture a piece of the expanding Chinese market, and Catalent Pharma Solutions intends to be among them. It has nailed down two deals that will give it manufacturing capacity there.

Catalent expands Chinese presence with two joint ventures

Catalent Pharma Solutions is betting big on the Chinese market, launching two joint ventures for its Softgel Technologies and Clinical Supply Solutions businesses.

Catalent puts $20M into nasal drug delivery

Catalent Pharma Solutions is again expanding its manufacturing operations in North Carolina, this time to build new capacity for inhalation drugs.

Catalent cuts 45 at U.K. plant as demand 'changes'

Catalent Pharma Solutions says the demand for products at its plant in Swindon, U.K., is "changing," and so it is reducing head count there by nearly four dozen employees.

Catalent, Parexel team up for trial supply

Catalent Pharma Solutions and Parexel International have joined forces to streamline the supply chain for clinical trials, saying their combined expertise can cover clients from early-stage planning to post-trial disposal.

Catalent targets South Korea with CTC Bio partnership

Catalent Pharma Solutions has teamed up with South Korea's CTC Bio to attract clients looking to market solid oral dose and controlled-release products in the U.S. and Europe.

Filling services help Dalton seal manufacturing deal with Clarity

The Toronto CMO has a manufacturing services agreement with Clarity Pharmaceuticals, providing cGMP chemistry manufacturing, scale up, aseptic fill and finish services and analytical support for the Australian radiopharmaceutical company.